Shenzhen Weiguang Biological Products Co., Ltd. (SHE:002880)
21.17
-0.32 (-1.49%)
Oct 14, 2026, 10:00 AM CST
SHE:002880 Revenue
Shenzhen Weiguang Biological Products had revenue of 227.19M CNY in the quarter ending June 30, 2026, a decrease of -22.49%. This brings the company's revenue in the last twelve months to 1.20B, down -0.06% year-over-year. In the year 2025, Shenzhen Weiguang Biological Products had annual revenue of 1.27B with 5.28% growth. That makes Shenzhen Weiguang Biological Products the 18,239th largest company in the world by revenue and 3,319th in China.
Revenue (ttm)
1.20B
Revenue Growth
-0.06%
P/S Ratio
4.07
Revenue / Employee
1.33M
Employees
901
Market Cap
4.80B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.27B | 63.47M | 5.28% |
| Dec 31, 2024 | 1.20B | 154.69M | 14.75% |
| Dec 31, 2023 | 1.05B | 380.57M | 56.98% |
| Jan 1, 2023 | 667.93M | -239.50M | -26.39% |
| Jan 1, 2022 | 907.43M | 2.87M | 0.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Anhui Huaheng Biotechnology | 3.00B |
| Youcare Pharmaceutical Group | 2.46B |
| Kexing Biopharm | 1.44B |
| ChemPartner PharmaTech | 1.16B |
| Boji Medical Technology | 961.34M |
| Beijing Konruns Pharmaceutical | 917.05M |
| Wuhan Keqian Biology Co.,Ltd | 836.28M |
| Beijing Bohui Innovation Biotechnology Group | 816.14M |